Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46

Wei Ling Ooi; Martin Stockler; Dickon Hayne

doi:10.1016/j.eururo.2011.03.050

Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46

Wei Ling Ooi, Martin Stockler, Dickon Hayne

Surgery

Research output: Contribution to journal › Letter › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	e1
Journal	European Urology
Volume	60
Issue number	1
DOIs	https://doi.org/10.1016/j.eururo.2011.03.050
Publication status	Published - 1 Jul 2011

Access to Document

10.1016/j.eururo.2011.03.050

Cite this

Ooi, W. L., Stockler, M., & Hayne, D. (2011). Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46. European Urology, 60(1), e1. https://doi.org/10.1016/j.eururo.2011.03.050

Ooi, Wei Ling ; Stockler, Martin ; Hayne, Dickon. / Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder : Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46. In: European Urology. 2011 ; Vol. 60, No. 1. pp. e1.

@article{2dd0ef131b81432c8308db9c7a5dff04,

title = "Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Gu{\'e}rin and with bacillus Calmette-Gu{\'e}rin alone in patients with carcinoma in situ of the urinary bladder: Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46",

author = "Ooi, {Wei Ling} and Martin Stockler and Dickon Hayne",

year = "2011",

month = jul,

day = "1",

doi = "10.1016/j.eururo.2011.03.050",

language = "English",

volume = "60",

pages = "e1",

journal = "European Urology",

issn = "0302-2838",

publisher = "Pergamon",

number = "1",

}

Ooi, WL, Stockler, M & Hayne, D 2011, 'Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46', European Urology, vol. 60, no. 1, pp. e1. https://doi.org/10.1016/j.eururo.2011.03.050

Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46. / Ooi, Wei Ling; Stockler, Martin; Hayne, Dickon.
In: European Urology, Vol. 60, No. 1, 01.07.2011, p. e1.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder

T2 - Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46

AU - Ooi, Wei Ling

AU - Stockler, Martin

AU - Hayne, Dickon

PY - 2011/7/1

Y1 - 2011/7/1

UR - http://www.scopus.com/inward/record.url?scp=79957955365&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2011.03.050

DO - 10.1016/j.eururo.2011.03.050

M3 - Letter

C2 - 21489685

AN - SCOPUS:79957955365

SN - 0302-2838

VL - 60

SP - e1

JO - European Urology

JF - European Urology

IS - 1

ER -

Ooi WL, Stockler M, Hayne D. Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: Results of an EORTC Genito-Urinary Group randomized phase 2 trial (30993). Eur Urol 2011;59:438-46. European Urology. 2011 Jul 1;60(1):e1. doi: 10.1016/j.eururo.2011.03.050

Access to Document

Other files and links

Cite this